H. Nakamine et al., PROGNOSTIC-SIGNIFICANCE OF CLINICAL AND PATHOLOGICAL FEATURES IN DIFFUSE LARGE B-CELL LYMPHOMA, Cancer, 71(10), 1993, pp. 3130-3137
Background and Methods. The diffuse large cell non-Hodgkin lymphomas a
re a heterogeneous group of neoplasms that are potentially curable. To
identify important predictors of clinical outcome, the authors evalua
ted the clinical and pathologic features of 114 patients with newly di
agnosed diffuse large B-cell lymphoma who were uniformly staged and tr
eated with curative intent. The authors were particularly interested i
n determining whether any pathologic features added to the ability of
the clinical features to predict patient survival. Results. Several cl
inical and pathologic features were found to be associated with surviv
al by univariate analysis. However, multivariate analysis disclosed th
at only the stage of disease and the symptom status were significantly
associated with survival. Low stage and lack of B symptoms were favor
able indicators of overall survival and failure-free survival. Conclus
ions. The authors suggest that the evaluation of pathologic features i
n diffuse large B-cell lymphoma has little prognostic utility and reco
mmend that the pathology evaluation be limited to features that are us
eful for diagnostic purposes.